Qualitas Health, known as iwi, produces plant-based omega-3 and protein supplements sold direct-to-consumer and to retailers across the United States. Its nutrition ingredients are sustainably sourced from company-owned cultivation pond systems the size of football fields in New Mexico and Texas. The company plans to accelerate sales of existing products and ramp development, marketing, and growth of new protein-based products, and to enter international markets. The business recently received an $8 million financing package comprising $5.5 million in senior secured term debt and a $2.5 million direct equity investment. Other investors in the company include Grupo Indukern, Gullspång Re:food VC, PeakBridge VC, Arancia Group, Trucent, SASA, and Minrav. The company is based in Houston. Qualitas Health, doing business as iwi, produces proprietary, clinically proven, high-absorption polar lipid EPA omega-3 derived from plant sources. Led by CEO Miguel Calatayud and founded by Erich Sieber and Nadav Berger, the company markets 15 supplement SKUs in the U.S., including soft gels and functional gummies. iwi has built a strong direct-to-consumer platform and maintains a presence in more than 5,000 U.S. retailer outlets. The company completed a first close of a funding round, securing $10M at a $73M post-money valuation to support growth. Proceeds will be used to accelerate customer acquisition, commercialize its plant-based protein, deepen clinical science and intellectual property, and expand into additional geographies. The firm emphasizes clinical evidence and proprietary IP around its plant-based omega-3 formulation as it scales commercialization.

Total raised

$18M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Jan 2022